Last Price
116.78
Today's Change
-0.445 (0.37%)
Day's Change
116.46 - 117.50
Trading Volume
2,829,616
Market Cap
296 Billion
Shares Outstanding
2 Billion
Avg Volume
9,859,014
Avg Price (50 Days)
118.27
Avg Price (200 Days)
122.26
PE Ratio
21.63
EPS
5.40
Earnings Announcement
31-Oct-2024
Previous Close
117.23
Open
117.27
Day's Range
116.4675 - 117.5
Year Range
99.14 - 134.63
Trading Volume
2,835,776
1 Day Change
-0.35%
5 Day Change
0.63%
1 Month Change
1.46%
3 Month Change
-9.91%
6 Month Change
-5.68%
Ytd Change
3.16%
1 Year Change
8.86%
3 Year Change
62.41%
5 Year Change
43.87%
10 Year Change
102.25%
Max Change
29447.01%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—General
Description:
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.